Skip to content
lifestyle.ketodash.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
NovaBridge Biosciences
NovaBridge Biosciences Announces Expanded Givastomig Safety and Efficacy Data to be Presented at the European Society for Medical Oncology 2026
October 8, 2026
NovaBridge Appoints Martin Dewhurst to Board as Independent Director
September 8, 2026
NovaBridge Biosciences to Participate in September Investor Conferences
August 27, 2026
NovaBridge Reports First Half 2026 Financial Results and Highlights Pipeline Momentum and Strategic Execution
August 20, 2026
NovaBridge to Report First Half 2026 Financial Results and Provide a Corporate Update on Thursday, August 20, 2026
August 13, 2026
NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026
July 24, 2026
NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value
April 22, 2026
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026
March 3, 2026